4//SEC Filing
Sabba Stephen L 4
Accession 0001104659-21-078158
CIK 0000886163other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 2:26 PM ET
Size
9.3 KB
Accession
0001104659-21-078158
Insider Transaction Report
Form 4
Sabba Stephen L
Director
Transactions
- Award
Common Stock
2021-06-04+630→ 25,061 total - Award
Non-Qualified Stock Option (right to buy)
2021-06-04−3,269→ 3,269 totalExercise: $115.39Exp: 2031-06-04→ Common Stock (3,269 underlying)
Holdings
- 2,468
Non-Qualified Stock Option (right to buy)
Exercise: $117.58Exp: 2030-06-10→ Common Stock (2,468 underlying)
Footnotes (3)
- [F1]These securities, as represented in Column 5, include a grant of 630 restricted shares approved by the Board of Directors of the Company at the 2021 Meeting, which shares will vest in full on the earlier of (a) the date of the next annual meeting of the Company stockholders following the grant date or (b) on the first anniversary of the grant date.
- [F2]These securities, as represented in Column 5, were acquired by a grant of 3,269 shares approved by the Board of Directors of the Company at the 2021 Meeting. That grant (a) vests in full on the earlier of (i) the date of the next annual meeting of the Company stockholders following the grant date or (ii) on the first anniversary of the grant date, and (b) will vest immediately (i) upon a change in control or a hostile takeover of the Company or (ii) the death or permanent disability of the grantee if still serving at that time.
- [F3]These securities, as represented in Column 5, were acquired by a grant of 2,468 shares approved by the Board of Directors of the Company at the 2020 Meeting and are fully vested and exerciseable as more fully described on a Form 4 for this Reporting Person filed on June 12, 2020.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001442372
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 2:26 PM ET
- Size
- 9.3 KB